Small-molecule TFEB pathway agonists that ameliorate metabolic syndrome in mice and extend C. elegans lifespan
Activation of autophagy, via the transcription factor TFEB, is a promising strategy to treat metabolic diseases. Here, the authors report three novel classes of small molecules that promote TFEB nuclear translocation, and provide evidence for the therapeutic efficacy of these compounds in mice and w...
Main Authors: | Chensu Wang, Hanspeter Niederstrasser, Peter M. Douglas, Rueyling Lin, Juan Jaramillo, Yang Li, Nathaniel W. Oswald, Anwu Zhou, Elizabeth A. McMillan, Saurabh Mendiratta, Zhaohui Wang, Tian Zhao, Zhiqaing Lin, Min Luo, Gang Huang, Rolf A. Brekken, Bruce A. Posner, John B. MacMillan, Jinming Gao, Michael A. White |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2017-12-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-017-02332-3 |
Similar Items
-
Author Correction: Small-molecule TFEB pathway agonists that ameliorate metabolic syndrome in mice and extend C. elegans lifespan
by: Chensu Wang, et al.
Published: (2018-05-01) -
Surviving starvation simply without TFEB.
by: Alexander A Soukas, et al.
Published: (2019-05-01) -
Regulation of MITF and TFEB
by: Friedrichsen, Hans
Published: (2016) -
TFEB: A Emerging Regulator in Lipid Homeostasis for Atherosclerosis
by: Manman Li, et al.
Published: (2021-02-01) -
TFEB Biology and Agonists at a Glance
by: Mingyue Chen, et al.
Published: (2021-02-01)